Automobiles occupy a thrilling space in the market where history, art, and speed intertwine ... from 3.0 to 5.0 liters, making Porsche's previous race car, the 908, non-competitive.

The I.C.E. St. Moritz was a true celebration of elegance, art, and pure motoring passion. More than 20,000 people made their ...

Shares of 908 Devices (NASDAQ:MASS) climbed ~71% in the premarket on Tuesday after Repligen (NASDAQ:RGEN) offered $70M in cash to acquire the company’s bioprocessing analytics portfolio.

908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device ...

908 Devices sold its desktop portfolio to Repligen for $70 million, reducing $20 million in annual operating losses. 908 Devices expects 2025 revenue of $53 million-$55 million, with EBITDA ...

The company said, “908 Devices (MASS) expects full year 2025 revenues from continuing operations of $53 million to $55 million, representing 11% to 15% growth compared to 2024 revenue from ...

On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.

The Porsche 911 GT3 2018 for sale in the Netherlands is a unique model, featuring a hand-painted custom design by renowned ...

908 Devices Inc. (MASS) reported a notable 31% year-over-year increase in revenue for the fourth quarter of 2024, reaching $18.8 million. This performance significantly surpassed market expectations.